Home LiteratureArticle Details
PMID: 2580588 Published · ppublish English Journal Article

Hepatic resection in the treatment of hepatocellular carcinoma: report of 60 cases.

The British journal of surgery ·Vol. 72 ·No. 4 ·1985-04-00 ·Pages 292-5

Nagasue N, Yukaya H, Ogawa Y, Sasaki Y, Akamizu H, Hamada T

Abstract

During the last 3 years and 9 months, hepatic resections were carried out on 60 patients with hepatocellular carcinoma (HCC). The resections were radical in 44 and palliative in 16 cases. Simultaneous operations were performed for oesophageal varices in 11 (9 prophylactic and 2 therapeutic) and for cholelithiasis in 9 patients. Fifty-nine patients had underlying hepatic disease; 52 had cirrhosis and 7 chronic hepatitis. Operative mortality rate within 1 month was 10 per cent and overall hospital mortality rate was 16.7 per cent. Excluding operative and hospital deaths, 76.8 per cent of patients who had radical excision and 18.8 per cent with palliative resections are alive. The result indicates that HCCs are frequently resectable even in the presence of liver cirrhosis provided that they are discovered at a relatively early stage.

MeSH Terms
Adolescent Adult Aged Carcinoma, Hepatocellular/complications,surgery Esophageal and Gastric Varices/complications Female Hepatectomy Humans Liver Cirrhosis/complications Liver Neoplasms/complications,surgery Male Middle Aged Palliative Care Postoperative Complications
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Nagasue N
Yukaya H
Ogawa Y
Sasaki Y
Akamizu H
Hamada T
Article Info
Journal
The British journal of surgery
Abbr.
Br J Surg
ISSN
0007-1323
Published
1985-04-00
Pages
292-5
Language
English
Region
England
NLM ID
0372553
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com